CAS: 3097-08-3; Magnesium Dodecyl Sulfate

该化合物是一种属于硫酸盐酯类别的化学化合物,其产物为乙酸盐,酒精和硫酸铵,一般是白色或白色粉末或固体.该化合物因其表面活性特性而闻名,能够有效减少表面张力,增强配方的湿化和乳化能力. 硫酸铵经常用于个人护理产品,如香波和洗涤体,因为它能够生成,改进清洗行动.此外,该化合物可以作为各种配方中的增厚剂和稳定剂.一般认为该化合物较轻,与其他硫酸盐相比不那么刺激,因此适合敏感的皮肤应用.然而,与任何化学品一样,必须小心处理该化合物,并遵循安全准则,以尽量减少使用该化合物可能带来的任何风险.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-10793495-B2
    优先权日:2015-08-14
    标 题:Synthesis of polyaryl substituted aryl compounds
    发明人:BOULOS RAMIZ; FEUTRILL JOHN
    权利人:BOULOS & COOPER PHARMACEUTICALS PTY LTD
    摘要:A method for the synthesis of a aryl compound of Formula (1).n nU T-W—R 1 ) n    (1)

    专利号:US-12221452-B2
    优先权日:2017-10-04
    标题:Synthesis of cantharidin
    发明人:DAVIDSON MATTHEW GENE; EKLOV BRIAN MATTHEW; WUTS PETER; LOERTSCHER BRAD MELVIN; SCHOW STEVEN R
    权利人:VERRICA PHARMACEUTICALS INC
    摘要:The invention provides synthetic methods for the preparation of cantharidin and analogs thereof. In one aspect, the invention provides an improved Diels-Alder cycloaddition to generate a key intermediate en route to cantharidin and analogs thereof. In certain embodiments, the new Diels-Alder reaction involves reacting Compound (2) in the presence of furan, and in the absence of acid or increased pressure, in an aprotic polar solvent with slight warming, to yield Compound (1) in favorable yield and exo-endo ratio. In another aspect, the invention also provides a new Diels-Alder reaction between compounds of Formula (III) and furan to yield compounds of Formula (IV), which can then be transformed into cantharidin or analogs thereof. In yet another aspect, the invention describes a new palladium-mediated carbonylation providing another key intermediate en route to cantharidin and analogs thereof. In addition to synthetic methods, present invention also provides compounds (i.e., intermediates) useful in the synthesis of cantharidin and analogs thereof. Compounds provided herein may have biological activity, and therefore may be used in the treatment of diseases or conditions (e.g., infectious diseases and skin conditions).

    专利号:US-11155562-B2
    优先权日:2014-06-30
    标 题 :Synthesis of halichondrin analogs and uses thereof
    发明人:KISHI YOSHITO; UEDA ATSUSHI; YAMAMOTO AKIHIKO; KATO DAISUKE
    权利人:HARVARD COLLEGE
    摘要:The present invention provides halichondrin analogs, such as compounds of Formula (I). The compounds may bind to microtubule sites, thereby inhibiting microtubule dynamics. Also provided are methods of synthesis, pharmaceutical compositions, kits, methods of treatment, and uses that involve the compounds for treatment of a proliferative disease (e.g., cancer). Compounds of the present invention are particularly useful for the treatment of metastatic breast cancer, non-small cell lung cancer, prostate cancer, and sarcoma. The included methods of synthesis are useful for the preparation of compounds of Formula (I)-(III) along with naturally occurring halicondrins (e.g., halichondrin B & C, norhalichondrin A, B, & C, and homohalichondrin A, B, & C). Also included are methods for interconverting between the halichondrins, norhalichondrins, and homohalichondrins and their unnatural epimers at the C38 ketal stereocenter through the use of an acid-mediated equilibration.

    专利号:US-9982005-B2
    优先权日:2013-04-04
    标 题 :Macrolides and methods of their preparation and use
    发明人:MYERS ANDREW G; SEIPLE IAN BASS; ZHANG ZIYANG
    权利人:HARVARD COLLEGE
    摘要:Provided herein are methods of preparing macrolides by the coupling of an eastern and western half, followed by macrocyclization, to provide macrolides, including both known and novel macrolides. Intermediates in the synthesis of macrolides including the eastern and western halves are also provided. Pharmaceutical compositions and methods of treating infectious diseases and inflammatory conditions using the inventive macrolides are also provided. A general diastereoselective aldol methodology used in the synthesis of the western half is further provided.

    专利号:US-11717498-B2
    优先权日:2013-12-31
    标题 :Methods of treatment using amphetamine controlled release, prodrug, and abuse deterrent dosage forms
    发明人:POPP KARL; MECKLER HAROLD
    权利人:Chemapotheca LLC; PHARMAPOTHECA A INC
    摘要:The invention also relates to pharmaceutical compositions comprising highly pure amphetamine and amphetamine-class compounds resulting from the synthesis of chiral and racemic amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds, and to methods of manufacturing, delivering, and using the amphetamine compounds resulting from the synthesis of chiral and racemic amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds.

    专利号:US-2014378538-A1
    优先权日:2011-12-14
    标 题:Methods of responding to a biothreat
    发明人:BANCEL STEPHANE
    权利人:MODERMA THERAPEUTICS INC
    摘要:The present disclosure provides for devices, in particular mobile devices, which may be used in the synthesis of modified nucleic acid molecules, in particular modified mRNA molecules. The device for making the modified nucleosides, modified nucleotides and modified nucleic acids (e.g., mRNA) disclosed herein may be mobile devices comprising at least one sample block for insertion of one or more sample vessels, a device base with electronic control units for the sample block, a voltage supply, and one or more reagent(s) for the synthesis of at least one nucleic acid.
    武汉弘德悦欣医药科技有限公司
    小微企业
    信用代码: 91420102MA4K4WB79G法定代表人:袁洪杰
    注册资本:180万(元)企业类型:有限责任公司(自然人投资或控股)
    成立日期:2019-07-31登记机关:武汉市江岸区市场监督管理局
    注册地址: 武汉市江岸区车站路6号怡东大厦19层F室
    医药、生物工程、生物制品的技术开发、技术服务;医药中间体、化学助剂及化工产品(不含化学危险品)的销售。(依法须经审批的项目,经相关部门审批后方可开展经营活动)
    免费会员展台
    http://www.hongdepharma.com
    企业联系电话:027-83855396👤
    📞 山东昱轩化工产品有限公司
    产品销售经理: 吴经理
    手机: 13657260109
    邮件: 2143879032@qq.com
    ⚠️ 声明: 咨询或交易时请注意风险评估和信息核实,百琢研不参与任何交易。

    地址: 武汉市江岸区车站路6号怡东大厦19层F室
    常规和库存产品*产品总量: 509

    平台资质认证✓营业执照✓
    十二烷基硫酸镁
    Magnesium Dodecyl Sulfate
    产品图片纯度:85%
    250kg/drum
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:S13 | EUCOSMETICS | Combined Inventory of Ingredients Employed in Cosmetic Products (2000) and Revised Inventory (2006) | DOI:10.5281/zenodo.2624118
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知